January month is the Thyroid awareness month, and it is a great way to comprehend the treatment, prevention, and causes of thyroid-related diseases and cancer for the people who are affected.
One of them is Thyroid eye disease, which is also known as Graves’ Orbitopathy or Ophthalmopathy that is an autoimmune disease. It occurs when the body’s immune system attacks the tissue surrounding the eye, causing inflammation in the tissues around and behind the eye.
DelveInsight Blog
Thyroid awareness month
Jan 28, 2020 | Reading Time: < 1 minute
Related Article

Ipsen to Acquire Albireo; Chiesi Farmaceutici to Buy Amryt Pharma; Takeda Presents Phase III Results of TAK-755 for cTTP; ACELYRIN Acquires ValenzaBio; FDA Approves LEQEMBI for Alzheimer’s Disease; Orphan Drug Designation to Lantern Pharma’s LP-284 for MLL
Ipsen to Acquire Albireo for USD 952 Million Ipsen, a French pharmaceutical company, has offered USD 42 per share for the US biotech Albireo and its rare disease treatment Bylvay, continuing a recent spree of merger and acquisition activity. Albireo, a Boston-based business, is valued at USD 952 million under th...
Find More
Thyroid eye disease market: New therapies enter the TED market
The newly approved drug teprotumumab can offer hope to adults with thyroid eye disease, a rare and potentially blinding condition. It's the first treatment specifically approved for thyroid eye disease. The drug of Horizon Therapeutics was approved by the U.S. Food and Drug Administration and is set to be marketed ...
Find More
Orthopedic Implants: Evaluating the Market Potential of the Unparalleled & Life-Saving Equipment
Musculoskeletal disorders are one of the most common disorders affecting a significant proportion of the population worldwide. They can have severe long-term pain, high levels of physical disability, various types of psychological distress, and reduced quality of life. As per the WHO (2022), musculoskeletal conditi...
Find MoreEditor's Pick
Newsletter/Whitepaper
Recent Article
ASCO Conference 2022

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.